Literature DB >> 18628775

Dilated cardiomyopathy: an unusual complication of clozapine therapy.

Badira Makhoul1, Irit Hochberg, Shmuel Rispler, Zaher S Azzam.   

Abstract

BACKGROUND: A 42-year-old obese man presented with acute pulmonary edema. He had a history of chronic residual schizophrenia for which he had been taking clozapine for 7 years, but had no known prior cardiac disease. Echocardiography demonstrated severe biventricular systolic and diastolic dysfunction with severe left ventricular enlargement. Cardiac catheterization showed no coronary artery disease. INVESTIGATIONS: Physical examination, chest radiography, electrocardiography, transthoracic echocardiography, laboratory testing, viral serology, cardiac catheterization, coronary angiography and abdominal and renal ultrasonography. DIAGNOSIS: Clozapine-induced dilated cardiomyopathy. MANAGEMENT: Intravenous nesiritide, furosemide and morphine followed by oral heart-failure therapy comprising ramipril, metoprolol succinate, spironolactone, and furosemide. Clozapine therapy was withdrawn.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18628775     DOI: 10.1038/ncpcardio1292

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN: 1743-4297


  6 in total

Review 1.  Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

Authors:  Domenico De Berardis; Gabriella Rapini; Luigi Olivieri; Domenico Di Nicola; Carmine Tomasetti; Alessandro Valchera; Michele Fornaro; Fabio Di Fabio; Giampaolo Perna; Marco Di Nicola; Gianluca Serafini; Alessandro Carano; Maurizio Pompili; Federica Vellante; Laura Orsolini; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Ther Adv Drug Saf       Date:  2018-02-06

Review 2.  Cardiovascular Disease in Clozapine-Treated Patients: Evidence, Mechanisms and Management.

Authors:  Kathlyn J Ronaldson
Journal:  CNS Drugs       Date:  2017-09       Impact factor: 5.749

Review 3.  Antipsychotic-induced hyponatraemia: a systematic review of the published evidence.

Authors:  Didier Meulendijks; Cyndie K Mannesse; Paul A F Jansen; Rob J van Marum; Toine C G Egberts
Journal:  Drug Saf       Date:  2010-02-01       Impact factor: 5.606

Review 4.  Systematic Review of Clozapine Cardiotoxicity.

Authors:  Martina Curto; Nicoletta Girardi; Luana Lionetto; Giuseppino M Ciavarella; Stefano Ferracuti; Ross J Baldessarini
Journal:  Curr Psychiatry Rep       Date:  2016-07       Impact factor: 5.285

Review 5.  [Fatigue, breathlessness and chest pain in a 31-year-old man with schizoaffective disorder].

Authors:  L Mizera; K Klingel; M Gawaz; S Greulich
Journal:  Internist (Berl)       Date:  2019-11       Impact factor: 0.743

6.  Arrhythmogenic right ventricular cardiomyopathy in a patient with schizophrenia.

Authors:  Kenta Kawasaki; Kotaro Miyaji; Satoshi Kodera; Yoshio Suzuki; Junji Kanda; Masayuki Ikeda
Journal:  Clin Case Rep       Date:  2015-02-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.